ATFX Maintains Strong Momentum in 2025 with USD 709.2 Billion in Q3
HONG KONG, Oct. 29, 2025 /PRNewswire/ -- Finance Magnates' Q3 2025 Intelligence Report highlights ATFX's continued strength and growing influence in the global trading landscape. During the quarter, ATFX achieved a total trading volume of USD 709.2...
Eason Technology Limited Received NYSE American Non-Compliance Letter
HONG KONG, Oct. 21, 2025 /PRNewswire/ -- Eason Technology Limited ("Eason Technology" or the "Company") (NYSE: DXF) today announced that it received a notice from NYSE Regulation indicating that the Company is not in compliance with the continued...
NaaS Technology Inc. Received Nasdaq Notification Regarding Minimum Market Value Deficiency
BEIJING, June 21, 2025 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that it has received written notification (the "MVLS Notice") from the...
RemeGen's Telitacicept (RC18) Received Orphan Drug Designation from EMA for Myasthenia Gravis
YANTAI, China, June 17, 2025 /PRNewswire/ -- On June 16, 2025, RemeGen Co., Ltd. ("RemeGen", stock symbols: 688331.SH/09995.HK) announced that telitacicept (RC18; brand name: 泰爱®) has received Orphan Drug Designation (ODD) from European Medicines...
The 3rd Tallest Office Building in Hong Kong Central Plaza Awarded 4 Platinum Building Certifications
Acknowledgement as a Green and Sustainable Grade-A Office Building Committed to Optimising Service Quality in a Comfortable Environment HONG KONG, June 11, 2025 /PRNewswire/ -- Central Plaza in Wan Chai is pleased to announce it has been awarded...
VivaVision Announces Positive Comments from FDA for the Type C Meeting Regarding VVN461LD for Post-operative Infalmmation - Agreeing the Phase 2 Trial to Be Served as One of the Two Pivotal Studies.
HONG KONG and WENZHOU, China, June 10, 2025 /PRNewswire/ -- VivaVision Biotech (VivaVision), a late clinical-stage, privately-held biotech company focused on developing innovative ophthalmic drugs, announced today that it received written...
33 Financial Group Launches Groundbreaking Shopping Mall Dining Gift Card Receives Prestigious UnionPay Gold Award for Transaction Volume Leadership
HONG KONG, June 9, 2025 /PRNewswire/ -- 33 Finance (SVF License No.: SVF0010), Hong Kong's leading gift card provider, announced the launch of its first dining gift card "Food Pass in Delight" in collaboration with ELEMENTS. The company was...
ESR Secures Top International Design Awards for the Fourth Year Running, Setting New Industry Benchmarks in 2025
WILMINGTON, Del., March 13, 2025 /PRNewswire/ -- ESR, a leading tech accessories brand, has been once again recognized for its commitment to innovation and design excellence by securing prestigious international design awards in 2025. The company's...
AIM Vaccine's Serum-Free Iterative Rabies Vaccine Has Received Production License and Will Submit for Market Registration
Launch of Major Product Expected to Significantly Drive Performance Growth HONG KONG, March 12, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 12, 2025, the company's...
Fosun Pharma Received NMPA Approval for Wan Ti Le (Tenapanor Hydrochloride Tablets)
Bringing New Hope to Chinese Dialysis Patients with Hyperphosphatemia SHANGHAI, Feb. 26, 2025 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma; stock code: 600196.SH, 02196.HK) announced that its holding subsidiary,...